- Standort
-
Deutsche Nationalbibliothek Frankfurt am Main
- ISSN
-
1477-9560
- Umfang
-
Online-Ressource
- Sprache
-
Englisch
- Anmerkungen
-
online resource.
- Erschienen in
-
Aspects of prophylactic treatment of hemophilia ; volume:14 ; number:1 ; day:4 ; month:10 ; year:2016 ; pages:59-63 ; date:10.2016
Thrombosis journal ; 14, Heft 1 (4.10.2016), 59-63, 10.2016
- Urheber
-
Ljung, Rolf
- Beteiligte Personen und Organisationen
-
SpringerLink (Online service)
- DOI
-
10.1186/s12959-016-0103-3
- URN
-
urn:nbn:de:1111-201610303760
- Rechteinformation
-
Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Letzte Aktualisierung
-
14.08.2025, 10:50 MESZ
Datenpartner
Dieses Objekt wird bereitgestellt von:
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Beteiligte
- Ljung, Rolf
- SpringerLink (Online service)
Ähnliche Objekte (12)
Psychological Aspects of Training for home Treatment in Hemophilia
Comparative Effectiveness of Valoctocogene Roxaparvovec and Prophylactic Factor VIII Replacement in Severe Hemophilia A
Model-Informed Support of Dose Selection for Prophylactic Treatment with Dalcinonacog Alfa in Adult and Paediatric Hemophilia B Patients
Understanding treatment burden in hemophilia: development and validation of the Hemophilia Treatment Experience Measure (Hemo-TEM)
Factor VIII prophylactic therapy reduces neurological complications in patients with Hemophilia A
Feasibility of Antifibrinolytic Treatment in Hemophilia: Preliminary Study
Evaluating the Effectiveness of Prophylactic Strategies for Hemophilia A Management: A Real-World, Longitudinal Observational Study
Oral Prophylactic Therapy in Hemophilia A and B (Factor VIII and IX Deficiencies)
Pathogenesis and treatment of osteoporosis in patients with hemophilia
Costs and utilization of treatment in patients with hemophilia
Advanced therapies for the treatment of hemophilia: future perspectives
Home Treatment for Children with Hemophilia
Psychological Aspects of Training for home Treatment in Hemophilia
Comparative Effectiveness of Valoctocogene Roxaparvovec and Prophylactic Factor VIII Replacement in Severe Hemophilia A
Model-Informed Support of Dose Selection for Prophylactic Treatment with Dalcinonacog Alfa in Adult and Paediatric Hemophilia B Patients
Understanding treatment burden in hemophilia: development and validation of the Hemophilia Treatment Experience Measure (Hemo-TEM)
Factor VIII prophylactic therapy reduces neurological complications in patients with Hemophilia A
Feasibility of Antifibrinolytic Treatment in Hemophilia: Preliminary Study
Evaluating the Effectiveness of Prophylactic Strategies for Hemophilia A Management: A Real-World, Longitudinal Observational Study
Oral Prophylactic Therapy in Hemophilia A and B (Factor VIII and IX Deficiencies)
Pathogenesis and treatment of osteoporosis in patients with hemophilia
Costs and utilization of treatment in patients with hemophilia
Advanced therapies for the treatment of hemophilia: future perspectives
Home Treatment for Children with Hemophilia
Psychological Aspects of Training for home Treatment in Hemophilia
Comparative Effectiveness of Valoctocogene Roxaparvovec and Prophylactic Factor VIII Replacement in Severe Hemophilia A
Model-Informed Support of Dose Selection for Prophylactic Treatment with Dalcinonacog Alfa in Adult and Paediatric Hemophilia B Patients
Understanding treatment burden in hemophilia: development and validation of the Hemophilia Treatment Experience Measure (Hemo-TEM)
Factor VIII prophylactic therapy reduces neurological complications in patients with Hemophilia A
Feasibility of Antifibrinolytic Treatment in Hemophilia: Preliminary Study
Evaluating the Effectiveness of Prophylactic Strategies for Hemophilia A Management: A Real-World, Longitudinal Observational Study
Oral Prophylactic Therapy in Hemophilia A and B (Factor VIII and IX Deficiencies)
Pathogenesis and treatment of osteoporosis in patients with hemophilia
Costs and utilization of treatment in patients with hemophilia
Advanced therapies for the treatment of hemophilia: future perspectives